R

Revenio Group Oyj
OMXH:REG1V

Watchlist Manager
Revenio Group Oyj
OMXH:REG1V
Watchlist
Price: 26.64 EUR -0.82% Market Closed
Market Cap: 710.8m EUR
Have any thoughts about
Revenio Group Oyj?
Write Note

Revenio Group Oyj
Investor Relations

Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Jouni Toijala B.Sc., M.B.A.
President & CEO
No Bio Available
Mr. Robin Pulkkinen M.Sc., M.Sc. (Econ)
Chief Financial Officer
No Bio Available
Mr. Ari Isomäki
Vice President of Operations
No Bio Available
Mr. Tomi Karvo M.B.A., M.Sc.
Vice President of Products, Brand & Marketing
No Bio Available
Mr. John Floyd
Vice President of Sales
No Bio Available
Ms. Hanna Vuornos
Vice President of People & Culture
No Bio Available
Kate Taylor
Vice President of Strategy & Business Development
No Bio Available

Contacts

Address
ETELA-SUOMEN
Vantaa
Ayritie 22
Contacts
+358987751150.0
www.reveniogroup.fi